These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2754805)

  • 1. [A new method for determination of DD/E complex using latex agglutination].
    Soe G; Kohno I; Motojima M; Saito M; Matsuda M; Terukina S
    Rinsho Byori; 1989 Apr; Spec No 81():176-82. PubMed ID: 2754805
    [No Abstract]   [Full Text] [Related]  

  • 2. [Quantitative analysis of crosslinked fibrin degradation products (XDP) in several diseases].
    Saito M; Asakura H; Ito K; Joukaji H; Uotani C; Kumabashiri I; Matsuda T
    Rinsho Ketsueki; 1988 Nov; 29(11):2042-7. PubMed ID: 3236412
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparison of 2 tests for determining lytic products of fibrin].
    Chalini-Carreon F; Ortiz-Méndez VM; Olvera-Hidalgo C; Magaña-Pérez JA
    Bol Med Hosp Infant Mex; 1983 Nov; 40(11):613-7. PubMed ID: 6651948
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative evaluation of D-dimer assays].
    Ikematsu S; Kuroso K
    Rinsho Byori; 1989 Apr; Spec No 81():189-97. PubMed ID: 2666686
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative evaluation of whole blood D-dimer test to plasma D-dimer test for diagnosis of disseminated intravascular coagulation.
    Gupta PK; Gupta M; Chatterjee T; Saxena R
    Indian J Exp Biol; 2005 Apr; 43(4):382-4. PubMed ID: 15875726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of a latex test for determining the fibrinogen/fibrin D-dimer (XDP)].
    Barsotti A; Savarino A
    Quad Sclavo Diagn; 1987 Dec; 23(4):421-4. PubMed ID: 3508302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of a test for plasma fibrin/fibrinogen degradation products (FDP) based on monoclonal anti-FDP antibody technology: an application for the scoring system of the disseminated intravascular coagulation (DIC) diagnostic criteria].
    Ito K; Wada H; Abe Y; Tomatsu H; Nishioka J; Nobori T
    Rinsho Byori; 2003 Apr; 51(4):295-9. PubMed ID: 12747249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparisons of hemagglutination inhibition, staphylococcal clumping, and latex agglutination tests for canine fibrinolytic degradation products.
    Chen JP; Williams TK; Legendre AM
    Am J Vet Res; 1981 Dec; 42(12):2049-52. PubMed ID: 7340573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of FDP-E analysis in blood coagulation and fibrinolysis tests].
    Horiuchi N; Aoki Y; Terada H
    Nihon Rinsho; 1989 Dec; 48 Suppl():896-900. PubMed ID: 2622026
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical significance of D Dimer analysis in blood coagulation and fibrinolysis tests].
    Kurokawa I; Kondo H
    Nihon Rinsho; 1989 Dec; 48 Suppl():901-5. PubMed ID: 2695675
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on latex agglutination test for fibrin degradation products (author's transl)].
    Isobe J; Hamai Y; Taharaguchi T; Watanabe H; Kusumoto M; Saito S
    Rinsho Byori; 1977 Oct; 25(10):843-7. PubMed ID: 599703
    [No Abstract]   [Full Text] [Related]  

  • 12. [FDP-E--quantitative analysis by LPIA (latex photometric immunoassay) method].
    Furusaki F; Sudo T; Tsutsui S
    Rinsho Byori; 1989 Apr; Spec No 81():168-75. PubMed ID: 2754804
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fibrin/fibrinogen degradation products (FDP)].
    Kuroso K; Fujimaki M
    Nihon Rinsho; 1989 Dec; 48 Suppl():892-5. PubMed ID: 2622025
    [No Abstract]   [Full Text] [Related]  

  • 14. Incidence and possible reasons for discordant results between positive FDP and negative D-dimer latex assays in clinical specimens.
    Song KS; Kim YA; Kim HK; Park Q
    Yonsei Med J; 1999 Apr; 40(2):107-11. PubMed ID: 10333712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Assay of products of fibrin and fibrinogen degradation in disseminated intravascular coagulations. Evaluation of a new technique].
    Borschneck C; Dreyfus M; Bridey F; Edouard D; Meyer D
    Presse Med; 1995 May 6-13; 24(17):799-802. PubMed ID: 7630868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of various rapid methods of determining fibrinogen transformation products in the diagnosis of intravascular coagulation and fibrinolysis].
    Lychev VG; Momot AP; Cherkashin GV
    Ter Arkh; 1984; 56(6):106-9. PubMed ID: 6474366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prototype quantitative assay for fibrinogen/fibrin degradation products. Clinical evaluation.
    Sigal SH; Cembrowski GS; Shattil SJ; Brown NM; Schifreen RS; Schwartz MW
    Arch Intern Med; 1987 Oct; 147(10):1790-3. PubMed ID: 3662708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of FDP].
    Ikematsu S; Kuroso K
    Rinsho Byori; 1985 Feb; Spec No 61():86-96. PubMed ID: 3889425
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of a new anti-fibrinogen-coated latex particle agglutination test in the measurement of serum fibrin degradation products.
    Marder VJ; Cruz GO; Schumer BR
    Thromb Haemost; 1977 Apr; 37(2):183-91. PubMed ID: 577622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biochemical studies in the postmortem diagnosis of the disseminated intravascular coagulation syndrome].
    Avramenko EP; Zoroastrov OM; Galian SL; Gladyshev SP; Lotter MG
    Sud Med Ekspert; 1998; 41(3):17-9. PubMed ID: 9703738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.